Cargando…

Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients

Stathmin1 (STMN1) regulates progression in various cancers. The present study aimed to determine the relationship between STMN1 expression and several cancer-related markers in breast cancer. Using immunohistochemistry, we evaluated STMN1, estrogen receptor, progesterone receptor, human epidermal gr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Obayashi, Sayaka, Horiguchi, Jun, Higuchi, Toru, Katayama, Ayaka, Handa, Tadashi, Altan, Bolag, Bai, Tuya, Bao, Pinjie, Bao, Halin, Yokobori, Takehiko, Nishiyama, Masahiko, Oyama, Tetsunari, Kuwano, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564402/ https://www.ncbi.nlm.nih.gov/pubmed/28766688 http://dx.doi.org/10.3892/ijo.2017.4085

Ejemplares similares

High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients
por: Bai, Tuya, et al.
Publicado: (2017)

Elevated expression of ΔNp63 in advanced esophageal squamous cell carcinoma
por: Kumakura, Yuji, et al.
Publicado: (2017)

Carboxypeptidase A4 accumulation is associated with an aggressive phenotype and poor prognosis in triple-negative breast cancer
por: Handa, Tadashi, et al.
Publicado: (2019)

Nuclear heat shock protein 110 expression is associated with poor prognosis and chemotherapy resistance in gastric cancer
por: Kimura, Akiharu, et al.
Publicado: (2016)

High expression of carcinoembryonic antigen and telomerase reverse transcriptase in circulating tumor cells is associated with poor clinical response to the immune checkpoint inhibitor nivolumab
por: Bao, Halin, et al.
Publicado: (2018)

Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma
por: Watanabe, Akira, et al.
Publicado: (2014)

Association of RAB5 overexpression in pancreatic cancer with cancer progression and poor prognosis via E-cadherin suppression
por: Igarashi, Takamichi, et al.
Publicado: (2017)

Nuclear heat shock protein 110 expression is associated with poor prognosis and hyperthermo-chemotherapy resistance in gastric cancer patients with peritoneal metastasis
por: Kimura, Akiharu, et al.
Publicado: (2017)

Carbonic anhydrase 9 expression is associated with poor prognosis, tumor proliferation, and radiosensitivity of thymic carcinomas
por: Ohtaki, Yoichi, et al.
Publicado: (2019)

Overexpression of karyopherin-α2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins
por: Tsukagoshi, Mariko, et al.
Publicado: (2017)

Poor prognosis in cholangiocarcinoma patients with low FBXW7 expression is improved by chemotherapy
por: Ishii, Norihiro, et al.
Publicado: (2017)

Reduced FBXW7 expression in pancreatic cancer correlates with poor prognosis and chemotherapeutic resistance via accumulation of MCL1
por: Ishii, Norihiro, et al.
Publicado: (2017)

High expression of forkhead box protein C2 is associated with aggressive phenotypes and poor prognosis in clinical hepatocellular carcinoma
por: Shimoda, Yuki, et al.
Publicado: (2018)

Mutant TP53 modulates metastasis of triple negative breast cancer through adenosine A2b receptor signaling
por: Horigome, Eisuke, et al.
Publicado: (2018)

Prognostic value of tumor-infiltrating lymphocytes in estrogen receptor-positive and human epidermal growth factor receptor 2-negative breast cancer
por: Honda, Chikako, et al.
Publicado: (2021)

TGF-β Signaling in Gastrointestinal Cancers: Progress in Basic and Clinical Research
por: Yokobori, Takehiko, et al.
Publicado: (2017)

Elucidation of the Anatomical Mechanism of Nodal Skip Metastasis in Superficial Thoracic Esophageal Squamous Cell Carcinoma
por: Kumakura, Yuji, et al.
Publicado: (2018)

Diagnostic value of (18)F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8(+)tumour-infiltrating lymphocytes in oral squamous cell carcinoma
por: Togo, Maria, et al.
Publicado: (2020)

Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine
por: Bilguun, Erkhem-Ochir, et al.
Publicado: (2020)

Cytoplasmic localization of connexin 26 suppresses transition of β‐catenin into the nucleus in intestinal‐ and mix‐type gastric cancer
por: Nakazawa, Nobuhiro, et al.
Publicado: (2022)

Stathmin 1 expression in plasma cell neoplasms
por: Machado-Neto, João Agostinho, et al.
Publicado: (2017)

Overexpression of natural killer group 2 member D ligands predicts favorable prognosis in cholangiocarcinoma
por: Tsukagoshi, Mariko, et al.
Publicado: (2016)

Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2022)

Low level of stromal lectin‐like oxidized LDL receptor 1 and CD8 (+) cytotoxic T‐lymphocytes indicate poor prognosis of colorectal cancer
por: Katayama, Chika, et al.
Publicado: (2021)

Mac-2-binding protein glycan isomer enhances the aggressiveness of hepatocellular carcinoma by activating mTOR signaling
por: Dolgormaa, Gantumur, et al.
Publicado: (2020)

Inflammatory and immune checkpoint markers are associated with the severity of aortic stenosis
por: Erkhem-Ochir, Bilguun, et al.
Publicado: (2020)

Increased Stathmin1 Expression in the Dentate Gyrus of Mice Causes Abnormal Axonal Arborizations
por: Yamada, Kohei, et al.
Publicado: (2010)

Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients
por: Kuang, Xia-Ying, et al.
Publicado: (2015)

Stathmin expression associates with vascular and immune responses in aggressive breast cancer subgroups
por: Askeland, Cecilie, et al.
Publicado: (2020)

Clinicopathological values of PD-L1 expression in HER2-positive breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2019)

Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors
por: Brattsand, G
Publicado: (2000)

Prognostic significance of tumour-infiltrating lymphocytes for oestrogen receptor-negative breast cancer without lymph node metastasis
por: Kurozumi, Sasagu, et al.
Publicado: (2019)

Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin
por: Ng, Dominic Chi Hiung, et al.
Publicado: (2006)

Clinical significance of Stathmin1 expression and epithelial-mesenchymal transition in curatively resected gastric cancer
por: Ke, Bin, et al.
Publicado: (2019)

Blood Group Substances as Potential Therapeutic Agents for the Prevention and Treatment of Infection with Noroviruses Proving Novel Binding Patterns in Human Tissues
por: Yazawa, Shin, et al.
Publicado: (2014)

Thyroid hormone suppresses expression of stathmin and associated tumor growth in hepatocellular carcinoma
por: Tseng, Yi-Hsin, et al.
Publicado: (2016)

Expression and phosphorylation of stathmin correlate with cell migration in esophageal squamous cell carcinoma
por: LIU, FEI, et al.
Publicado: (2013)

Stathmin levels alter PTPN14 expression and impact neuroblastoma cell migration
por: Po’uha, Sela T., et al.
Publicado: (2019)

Expression of stathmin in oral squamous cell carcinoma and its correlation with tumour proliferation
por: Rana, Satyadev, et al.
Publicado: (2023)

Treatment of multiple liver metastasis from gastric carcinoma
por: Ojima, Hitoshi, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_59j004kibo1m5kqoo4j4mne1s6